{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:01:09Z","timestamp":1792591269591,"version":"4.5.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/idoj.idoj_330_19","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:18:44Z","timestamp":1638764324000},"page":"307","source":"Crossref","is-referenced-by-count":24,"title":["Update on pharmacotherapy in psychodermatological disorders"],"prefix":"10.4103","volume":"11","author":[{"given":"Ravindra","family":"Munoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShrutakirthiD","family":"Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.284111-1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0049475517736708","article-title":"Psycho dermatology liaison clinic in India: A working model","author":"Goyal","year":"2018","journal-title":"Trop Doct"},{"key":"key-10.4103\/2229-5178.284111-2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0019-5154.105310","article-title":"Our experience in a psychodermatology liaison clinic at Manipal, India","author":"Shenoi","year":"2013","journal-title":"Ind J Dermatol"},{"key":"key-10.4103\/2229-5178.284111-3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CMR.00018-09","article-title":"Delusional infestation","author":"Freudenmann","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/2229-5178.284111-4","first-page":"1336","article-title":"A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania","author":"Van","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-5","first-page":"143","article-title":"Olanzapine is effective in the management of some self-induced dermatoses: Three case reports","author":"Gupta","year":"2000","journal-title":"Cutis"},{"key":"key-10.4103\/2229-5178.284111-6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archderm.1958.01560010121024","article-title":"A dermatologic and psychiatric study of perphenazine (trilafon) in dermatology","author":"Shanon","year":"1958","journal-title":"AMA Arch Dermatol"},{"key":"key-10.4103\/2229-5178.284111-7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.1961.tb14395.x","article-title":"Controlled trials of two oral antipruritic drugs, trimeprazine and methdilazine","author":"Smith","year":"1961","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.284111-8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1365-2133.2010.09969.x","article-title":"Quetiapine in the treatment of hyperhidrosis axillaris","author":"Dickmann","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.284111-9","doi-asserted-by":"crossref","unstructured":"Zomer SF, De Wit RF, Van Bronswijk JE, Nabarro G, Van Vloten WA. Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998;138:1030-2.","DOI":"10.1046\/j.1365-2133.1998.02272.x"},{"key":"key-10.4103\/2229-5178.284111-10","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jaad.2018.12.012","article-title":"Diagnosis and management of delusions of parasitosis","author":"Campbell","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-11","first-page":"97","article-title":"Delusions of parasitosis with folie a deux: A case series","author":"Sawant","year":"2015","journal-title":"Ind Psychiatry J","ISSN":"https:\/\/id.crossref.org\/issn\/0972-6748","issn-type":"print"},{"key":"key-10.4103\/2229-5178.284111-12","first-page":"352","article-title":"Successful treatment of delusions of parasitosis with olanzapine","author":"Meehan","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.284111-13","first-page":"1531","article-title":"Aripiprazole as a viable alternative for treating delusions of parasitosis","author":"Ladizinski","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/2229-5178.284111-14","first-page":"433","article-title":"Aripiprazole in delusional disorder","author":"Duvar","year":"2010","journal-title":"Eur J Gen Med"},{"key":"key-10.4103\/2229-5178.284111-15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clindermatol.2018.08.006","article-title":"Use of antipsychotic drugs in dermatology","author":"Gupta","year":"2018","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.284111-16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-17","unstructured":"Schatzberg AF, Cole JO, DeBattista C. Manual of Clinical Psychopharmacology. 4th ed. Washington: American Psychiatric Press; 2003."},{"key":"key-10.4103\/2229-5178.284111-18","first-page":"61","article-title":"Relevant issues in pharmacotherapy of psychocutaneous disorders","author":"Ghosh","year":"2013","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.284111-19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clindermatol.2011.11.013","article-title":"Use of psychotropic drugs in dermatology: Unique perspectives of a dermatologist and psychiatrist","author":"Park","year":"2013","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.284111-20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1983.03340060045024","article-title":"Long term diazepam therapy and clinical outcome","author":"Rickels","year":"1983","journal-title":"JAMA"},{"key":"key-10.4103\/2229-5178.284111-21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00004714-199912002-00003","article-title":"Pharmacologic strategies for discontinuing benzodiazepine treatment","author":"Rickels","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2045125317753340","article-title":"Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation","author":"Fluyau","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.9758\/cpn.2016.14.2.177","article-title":"The efficacy and safety of clonazepam in patients with anxiety disorder taking newer antidepressants: A multicenter naturalistic study","author":"Wang","year":"2016","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"key-10.4103\/2229-5178.284111-24","first-page":"69","article-title":"Psychopharmacology in Dermatology","author":"Lee","year":"2008","journal-title":"DermatolTher"},{"key":"key-10.4103\/2229-5178.284111-25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamadermatol.2018.4398","article-title":"Assessment of a bidirectional association between major depressive disorder and alopecia areata","author":"Vallerand","year":"2019","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.284111-26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","article-title":"Vitiligo and major depressive disorder: A bidirectional population-based cohort study","author":"Vallerand","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2017.08.025","article-title":"Use of oral antidepressants in patients with chronic pruritus: A systematic review","author":"Kouwenhoven","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-28","doi-asserted-by":"crossref","unstructured":"Munoli R. Primary Psychiatric Disorders \u2013 Cutaneous Manifestations. In: Latheef AE, Prabhu SS, Shenoi SD, editors. Handbook of Psychodermatology. 1st ed. New Delhi: Jaypee Brothers Medical Publishers PLtd; 2016. p. 30-49.","DOI":"10.5005\/jp\/books\/12889_6"},{"key":"key-10.4103\/2229-5178.284111-29","doi-asserted-by":"crossref","unstructured":"Kongasseri S. Secondary psychiatric disorders in dermatology patients. In: Latheef AE, Prabhu SS, Shenoi SD, editors. Handbook of Psychodermatology. 1st ed. New Delhi: Jaypee Brothers Medical Publishers PLtd; 2016. p. 50-62.","DOI":"10.5005\/jp\/books\/12889_7"},{"key":"key-10.4103\/2229-5178.284111-30","unstructured":"Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. 3rd ed. Philadelphia: WB Saunders 2001. p. 402-25."},{"key":"key-10.4103\/2229-5178.284111-31","unstructured":"Lee CS, Koo JY. Use of Psychotropics in dermatology. In: Koo JY, Lee CS, editors. Pychocutaneous Medicine. 1st ed. New York: Marcel Dekker Pubihsers; 2003. p. 427-52."},{"key":"key-10.4103\/2229-5178.284111-32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/PCC.v03n0105","article-title":"SSRI antidepressant medications: Adverse effects and tolerability","author":"Ferguson","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/15622975.2017.1379609","article-title":"Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement","author":"Dodd","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/joim.12093","article-title":"Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: A population-based cohort study","author":"Thorslund","year":"2013","journal-title":"J Intern Med"},{"key":"key-10.4103\/2229-5178.284111-35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000357353","article-title":"Use of selective serotonin reuptake inhibitors in the treatment of burning mouth syndrome","author":"Fleuret","year":"2014","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.284111-36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11204760-000000000-00000","article-title":"Escitalopram: A review of its use in the management of major depressive disorder in adults","author":"Garnock-Jones","year":"2010","journal-title":"CNS Drugs"},{"key":"key-10.4103\/2229-5178.284111-37","first-page":"367","article-title":"Efficacy of citalopram in treatment of pathological skin picking: A randomized double blind placebo controlled trial","author":"Arbabi","year":"2008","journal-title":"Acta Med Iran"},{"key":"key-10.4103\/2229-5178.284111-38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/YIC.0b013e32809913b6","article-title":"Open-label escitalopram treatment for pathological skin picking","author":"Keuthen","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v58n0802","article-title":"A double-blind trial of fluoxetine in pathologic skin picking","author":"Simione","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0733-8635(05)70373-9","article-title":"Body dysmorphic disorder","author":"Cotterill","year":"1996","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/2229-5178.284111-41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/hrp.7.2.69","article-title":"Selective serotonin-reuptake inhibitors: An update","author":"Masand","year":"1999","journal-title":"Harv Rev Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-199902000-00005","article-title":"An open clinical trial of fluvoxamine treatment of psychogenic excoriation","author":"Arnold","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/070674379904400808","article-title":"Obsessive-compulsive spectrum disorders: Effective treatment with paroxetine","author":"Ravindran","year":"1999","journal-title":"Can J Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00004583-200105000-00007","article-title":"Improvement of acne in depressed patients treated with paroxetine","author":"Moussavian","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-4362.2001.01261-3.x","article-title":"Paroxetine in alopecia areata","author":"Cipriani","year":"2001","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.284111-46","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.fertnstert.2009.04.039","article-title":"Adverse effect of paroxetine on sperm","author":"Tanrikut","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/2229-5178.284111-47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archderm.1996.03890290131022","article-title":"Sertraline in the treatment of neurotic excoriations and related disorders","author":"Kalivas","year":"1996","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.284111-48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4088\/JCP.v58n0702","article-title":"Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review","author":"Zajecka","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-49","unstructured":"O'Donnell JM, Shelton RC. Drug therapy of depression and anxiety disorders. In: Brunton IL, editor. Goodman and Goodman's the Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill Medical Publishing Division; 2006. p. 398-413."},{"key":"key-10.4103\/2229-5178.284111-50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1526-4637.2010.01035.x","article-title":"Burning mouth syndrome responsive to duloxetine: A case report","author":"Mignogna","year":"2011","journal-title":"Pain Med"},{"key":"key-10.4103\/2229-5178.284111-51","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/MJT.0b013e31823581c8","article-title":"Bupropion precipitating acute psychosis: A case report","author":"Munoli","year":"2014","journal-title":"Am J Ther"},{"key":"key-10.4103\/2229-5178.284111-52","first-page":"835","article-title":"Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: A pilot study","author":"Modell","year":"2002","journal-title":"Psychosom Med"},{"key":"key-10.4103\/2229-5178.284111-53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000288889","article-title":"Imipramine in alopecia areata.A double-blind, placebo-controlled study","author":"Perini","year":"1994","journal-title":"Psychother Psychosom"},{"key":"key-10.4103\/2229-5178.284111-54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0733-8635(05)70239-4","article-title":"Neurotropic and psychotropic drugs in dermatology","author":"Tennyson","year":"2001","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/2229-5178.284111-55","first-page":"e12993","article-title":"Doxepin in difficult-to-treat chronicurticaria: A retrospective, cross-sectional study from Turkey","author":"\u00d6zkaya","year":"2019","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/2229-5178.284111-56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0190-9622(85)70092-8","article-title":"Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria","author":"Greene","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archderm.134.3.327","article-title":"Scalp dysesthesia","author":"Hoss","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.284111-58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"key":"key-10.4103\/2229-5178.284111-59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","author":"Davis","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/2229-5178.284111-60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2004.01.045","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot study","author":"Hundley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-61","first-page":"176","article-title":"Psychodermatology: A comprehensive review","author":"Yadav","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.284111-62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14656566.2018.1472767","article-title":"Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: A meta-analytic review","author":"Gomez","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/2229-5178.284111-63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clindermatol.2011.11.014","article-title":"Psychiatric medications: Adverse cutaneous drug reactions","author":"Bliss","year":"2013","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.284111-64","unstructured":"Wolfgang HW, Gieler U, Kusnir D, Tausk FA. Psychopharmacological therapy in dermatology. In: Clinical Management in Psychodermatology. 1st ed. New York: Springer Publications; 2009. p. 239-58."},{"key":"key-10.4103\/2229-5178.284111-65","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.clindermatol.2018.08.005","article-title":"Use of antiepileptic mood stabilizers in dermatology","author":"Gupta","year":"2018","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.284111-66","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0b013e3181e617a1","article-title":"A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: Treatment efficacy and neurocognitive predictors of response","author":"Grant","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-67","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.jcp.0000088906.24613.76","article-title":"Effects of topiramate on aggressive, self-injurious, and disruptive\/destructive behaviors in the intellectually disabled: An open-label retrospective study","author":"Janowsky","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/2229-5178.284111-68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/2229-5178.284111-69","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1213\/00000539-199912000-00026","article-title":"Gabapentin therapy for vulvodynia","author":"Ben-David","year":"1999","journal-title":"Anesth Analg"},{"key":"key-10.4103\/2229-5178.284111-70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000078050","article-title":"Gabapentin in the treatment of glossodynia","author":"Meiss","year":"2004","journal-title":"Dermatol Psychosom"},{"key":"key-10.4103\/2229-5178.284111-71","first-page":"85","article-title":"Gabapentin for the treatment of recalcitrant chronic prurigo nodularis","author":"Dereli","year":"2008","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2229-5178.284111-72","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jaad.2018.12.031","article-title":"The uses of naltrexone in dermatological conditions","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.284111-73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamadermatol.2018.4093","article-title":"Utility of naltrexone treatment for chronic inflammatory dermatologic conditions: A systematic review","author":"Ekelem","year":"2019","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/2229-5178.284111-74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000480539","article-title":"Treatment of broadly defined behavioral addictions: A review and meta-analysis of randomized controlled trials","author":"Mouaffak","year":"2017","journal-title":"Eur Addict Res"},{"key":"key-10.4103\/2229-5178.284111-75","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4103\/ijdvl.IJDVL_33_18","article-title":"N-acetylcysteine in dermatology","author":"Adil","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.284111-76","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2016.0060","article-title":"N-acetylcysteine in the treatment of excoriation disorder: A randomized clinical trial","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"Nacetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double blind, placebocontrolled study","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaac.2012.12.020","article-title":"Nacetylcysteine in the treatment of pediatric trichotillomania: A randomized, doubleblind, placebocontrolled addon trial","author":"Bloch","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/2229-5178.284111-79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1871523011312030003","article-title":"N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial","author":"Ghanizadeh","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"key-10.4103\/2229-5178.284111-80","unstructured":"Nixiyax.org [homepage on the Internet]. Curatio Healthcare (I) Pvt. Ltd. Available from: http:\/\/www.niiyax.com\/. [updated 2019; Last cited on 2019 May 27]."}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:29Z","timestamp":1787163869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_330_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["284111"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_330_19","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}